Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

<< Previous

Bullboard Posts

Post by Closure70on Dec 03, 2024 5:19pm

62 Views

Post# 36343887

Still alive?

An idea for this play, how about repurposing our investment share into crytpo? by the looks of it, if you can find a way of doing that, it would be worth more than what it is today or ever going to be at this pace.

another year gone by, shres heavily diluted and basicall a loss waiting to happen for 2025.

Very disappointing to say the least and tired of hearing of all the great "ifs"

<< Previous

Bullboard Posts

3 Mid-Sized Stocks to Consider This Season